A new COVID-19 variant, dubbed Variant XFG or “Stratus,” is currently spreading within the United States and globally. According to a report from USA Today, existing COVID-19 vaccines are anticipated to provide continued protection against symptomatic and severe illness linked to this variant. The variant has been associated with a concerning rise in infections and hospital admissions in several Southeast Asian countries where it is prevalent.
As categorized by the World Health Organization (WHO), Variant XFG has been marked as a “variant under monitoring.” While initial data indicates that XFG does not lead to more severe illness or increased mortality relative to other circulating strains, its growth in case numbers is worth noting. The Centers for Disease Control and Prevention (CDC) reports high or very high case rates in states such as Alabama, Florida, Texas, and California. Additionally, other states including New York, Georgia, and Illinois are also witnessing increases in cases attributable to Variant XFG.
This new strain is a recombinant, resulting from the fusion of two earlier variants, F.7 and LP.8.1.2. Scientists have identified mutations within XFG that may enhance its ability to evade the immune system, although this does not necessarily correlate with a faster transmission rate. Initially detected in Southeast Asia in January, XFG’s presence in the U.S. has surged-accounting for nearly 0% of cases in March, rising to 14% by late June, according to CDC statistics. Globally, the WHO has reported a similar trend, with XFG making up 22.7% of cases across 38 countries by the end of June.
Despite these increases, the WHO has assessed the overall public health risk posed by XFG as “low.” The organization has also reaffirmed that current vaccines should remain effective against symptomatic and severe forms of the disease caused by this variant. The variant’s classification as a SARS-CoV-2 variant under monitoring brings it to the health community’s attention, although evidence so far does not present it as a primary threat.
Symptoms associated with COVID-19 continue to align with established indicators, which include fever, cough, fatigue, sore throat, and loss of taste or smell, among others. The public is urged to remain vigilant as this variant circulates, reinforcing the importance of vaccination and monitoring personal health.
As the situation evolves, health officials recommend staying informed through trusted sources to track the spread of Variant XFG and its implications. Vaccination remains a crucial tool in combating existing and emerging variants, emphasizing the importance of maintaining public health measures alongside vaccination campaigns.
This ongoing development highlights the necessity for continued surveillance and research into COVID-19 variants, ensuring that individuals and healthcare systems are equipped to respond effectively.
Original Source: https://www.hindustantimes.com/world-news/us-news/stratus-covid-variant-spreads-in-us-and-worldwide-all-you-need-to-know-101754816905671.html
Category :
Tags:
Publish Date: 2025-08-10 15:15:00
